Insider · CIK 0001965228
Fawad Ahmad
cooofficerdirector
Files at RDN (RADIAN GROUP INC), ADT (ADT Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | ADT ADT Inc. | AGrant or award Common Stock | +1,904 | $0.00 | $0 | 305,940 | 7 d ago |
| Oct 2, 2025 | ADT ADT Inc. | AGrant or award Common Stock | +1,975 | $0.00 | $0 | 316,127 | Oct 6, 2025 |
| Jul 8, 2025 | ADT ADT Inc. | AGrant or award Common Stock | +2,043 | $0.00 | $0 | 314,152 | Jul 10, 2025 |
| May 21, 2025 | RDN RADIAN GROUP INC | AGrant or award Restricted Stock Units - Time-based Awardderivative | +4,837 | - | - | 4,837 | May 23, 2025 |
| May 15, 2025 | RDN RADIAN GROUP INC | MOption exercise Common Stock | +5,109 | $0.00 | $0 | 10,994 | May 19, 2025 |
| May 15, 2025 | RDN RADIAN GROUP INC | FTax withholding Common Stock | -11 | $34.04 | $374 | 10,983 | May 19, 2025 |
| May 15, 2025 | RDN RADIAN GROUP INC | MOption exercise Restricted Stock Units - Time-based Awardderivative | -5,109 | - | - | 0 | May 19, 2025 |
| May 1, 2025 | ADT ADT Inc. | AGrant or award Common Stock | +312,109 | $0.00 | $0 | 312,109 | May 13, 2025 |
| May 1, 2025 | ADT ADT Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +374,531 | $0.00 | $0 | 374,531 | May 13, 2025 |
| May 1, 2025 | ADT ADT Inc. | AGrant or award Common Stock | +312,109 | $0.00 | $0 | 312,109 | May 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.